[1] 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28. Zheng RS, Sun KX, Zhang SW, et al. Report of cancer epidemiology in China, 2015[J]. Chinese Journal of Oncology, 2019,41(1):19-28. [2] 周家琛,郑荣寿,张思维,等.2000-2015年中国肿瘤登记地区食管癌发病及年龄变化趋势[J].中华肿瘤防治杂志,2020,27(18):1437-1442. Zhou JC, Zheng RS, Zhang SW, et al. Analysis on the trend of esophageal cancer incidence and age change in cancer registration areas of China, 2020 to 2015[J]. Chinese Journal of Cancer Prevention and Treatment, 2020,27(18):1437-1442. [3] 李琳,蔡晓军.阿帕替尼联合紫杉醇二线治疗晚期食管癌的临床研究[J].实用肿瘤杂志,2020,35(3):241-244. Li L, Cai XJ. Clinical study of apatinib combined with paclitaxel in second-line treatment of advanced esophageal cancer[J]. Journal of Practical Oncology, 2020,35(3):241-244. [4] Testa U, Castelli G, Pelosi E. Esophageal cancer: genomic and molecular characterization, stem cell compartment and clonal evolution[J/OL]. Medicines, 2017,4(3):67[2020-09-04]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622402/. DOI:10.3390/medicines4030067. [5] 何若瑜.周仲瑛教授食管癌、胃癌辨治比较研究[D].南京:南京中医药大学,2014. He RY. A comparative study of the esophageal cancer and the gastric cancer cases treating by professor Zhou Zhongying[D]. Nanjing: Nanjing University of Chinese Medicine, 2014. [6] 宋洋.经典名方通幽汤的组方及功能考证研究[D].哈尔滨:黑龙江中医药大学,2019. Song Y. Textual research on the prescription and function of the classic Tongyoutang[D]. Ha rbin: Heilongjiang: Heilongjiang University of Chinese Medicine, 2019. [7] 朱元秋.从肾论治食道癌呕吐案[J].中国民间疗法,2015,23(8):41. Zhu YQ. Treating vomiting cases of esophageal cancer from kidney[J]. China’s Naturopathy, 2015,23(8):41. [8] 赵文麟,谢晓佳,纪智,等.《内经》十二原本义探析[J].北京中医药大学学报,2015,38(6):369-372. Zhao WL, Xie XJ, Ji Z, et al. An analysis of the original meaning of twelve yuan in Huangdi Neijing[J]. Journal of Beijing University of Traditional Chinese Medicine, 2015,38(6):369-372. [9] 张晓艳,谢鹏雁.足三里穴与食管运动功能的研究进展[J].世界华人消化杂志,2009,17(11):1108-1111. Zhang XY, Xie PY. Advances in acupuncture at Zusanli (ST 36) on esophageal motor function[J]. World Chinese Journal of Digestology, 2009,17(11):1108-1111. [10] 周婷,李文涛,于建春,等.艾灸足三里对晚期恶性肿瘤患者生存质量的影响[J].中国针灸,2019,39(2):133-136,146. Zhou T, Li WT, Yu JC, et al. Impacts of moxibustion at Zusanli (ST 36) on the improvements in the quality of life in patients with advanced malignant tumor[J]. Chinese Acupuncture & Moxibustion, 2019,39(2):133-136,146. [11] 思志强,张莹,孙彬栩,等.足三里穴位注射在肿瘤治疗相关毒副反应中的应用[J].中医肿瘤学杂志,2020,2(2):63-66. Si ZQ, Zhang Y, Sun BX, et al. Application of Zusanli acupoint injection in cancer treatment[J]. Journal of Oncology in Chinese Medicine, 2020,2(2):63-66. [12] 孟丹华,李晨旭,尚艺婉,等.六君子汤治疗恶性肿瘤的研究进展[J].时珍国医国药,2020,31(1):172-174. Meng DH, Li CX, Shang YW, et al. Research progress of Liujunzi Decoction in the treatment of malignant tumor[J]. Lishizhen Medicine and Materia Medica Research, 2020,31(1):172-174. [13] 徐文,曹辉,杨远荣.人参皂苷Rh2的药理活性研究进展[J].中国医药导报,2017,14(28):42-45. Xu W, Cao H, Yang YR. Advances in pharmacological effects of ginsenoside Rh2[J]. China Medical Herald, 2017,14(28):42-45. [14] 刘阳,刘畅,罗英花,等.黄芪中有效成分对人食道癌HCE-4细胞凋亡的影响[J].药物评价研究,2016,39(3):377-381. Liu Y, Liu C, Luo YH, et al. Molecular mechanism of induction on apoptosis of human esophageal cancer HCE-4 cells by active components from Astragalus membranaceus[J]. Drug Evaluation Research, 2016,39(3):377-381. [15] Meng CT, Bai CM, Brown TD, et al. Human Gut Microbiota and Gastrointestinal Cancer[J/OL]. Genomics Proteomics Bioinformatics, 2018,16(1):33-49[2020-09-03]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000254/. DOI:10.1016/j.gpb.2017.06.002. |